Summary
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Clinical NeuroscienceReferences
- Cancer statistics.CA Cancer J Clin. 2003; 53: 5-26
- Cancer Statistics. CA Cancer J Clin. 2004; 54: 8-29
- Glioblastoma multiforme: an accumulated experience over 10 years.Acta Neurochir. 1995; 137: 29-33
- Brain tumour cooperative group trial 8001.J Neurosurg. 1989; 71: 1-12
- Current therapy for brain tumours.Arch Neurol. 1999; 56: 429-432
Levin VA. Chemotherapy of primary brain tumors. In: Frank BD, editor. Symposium on Neuro-oncology, vol. 3, Neurologic Clinics, 4th ed. York, Penn: WB Saunders; 1985. p. 855–866
- Chemotherapy for malignant gliomas.J Neurosurg. 1988; 68: 1-17
- Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine and vincrsitine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.J Rad Onc Biol Phys. 1990; 18: 321-324
- Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant glioma.EORTC Brain Tumour Group Neurol. 1994; 44: 1479-1483
- Photodynamic therapy of brain tumors.Semin Surg Oncol. 1995; : 335-345
- Photodynamic therapy for recurrent supratentorial gliomas.Semin Surg Oncol. 1995; 11: 346-354
- Photodynamic therapy for intracranial neoplasms. Literature review and institutional experience.Mol Chem Neuropathol. 1994; 21: 337-352
- Selective uptake of hematoporphyrin derivative into human cerebral glioma.Neurosurgery. 1990; 26: 248-254
- Photodynamic sensitizers.in: DeVita V.T. Hellman S. Rosenberg S.A. Cancer Principles and Practice of Oncology. 2nd ed. J.P. Lippincot, Philadelphia1985: 2272-2279
- Basic principles of photodynamic therapy.J Porphyr Phthalocyan. 2001; 5: 105-129
- Pathology and genetics of Tumours of the central nervous system.in: Kleihues P. Cavanee W.K. World Health Organization Classification of tumours. IARC Press, Lyon2000: 6-69
- The uptake and retention of hematoporphyrin derivative in an in vivo/in vitro model of cerebral glioma.Neurosurgery. 1985; 17: 883-890
- Quantitation of hematoporphyrin derivative in human gliomas, experimental central nervous system tumours and normal tissues.Neurosurgery. 1983; 12: 446-450
StataCorp 2001. Stata Statistical Software: Release 7.0. College Station, TX: Stata Corporation
- Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.Int J Radiat Oncol Biol Phys. 1989; 16: 1405-1409
- Long term survivors of glioblastoma: statistical aberration or important unrecognised molecular subtype?.Cancer J. 2003; 9: 214-221
- Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.J Neurosurg. 1978; 49: 333-343
- Primary brain tumors in adults.Lancet. 2003; 361: 323-331
- Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma.J Clin Oncol. 1993; 11: 77-83
- An analysis of radiotherapy data from the CNS Cancer Consortium’s randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumour.Am J Clin Oncol. 1993; 16: 277-283
- Benefits of adjuvant chemotherapy in high-grade gliomas.Semin Oncol. 2003; 30: 15-18
- Is the long-term survival of patients with intracranial glioblastoma multiforme overstated?.Cancer. 2003; 98: 1745-1748
- Which glioblastoma multiforme patient will become a long-term survivor? A population based study.Ann Neurol. 1999; 46: 183-188
- Long-term survival after malignant glioma: a clinical and histopathological study on the accuracy of the diagnosis in a population based cancer register.Acta Oncol. 1990; 29: 875-878
- Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials.J Clin Oncol. 1999; 17: 2572-2578
- Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.Cancer. 1993; 71: 2585-2597
- A phase II study of temozolomide vs. procarbazine in patients’ with glioblastoma multiforme at first relapse.Br J Cancer. 2000; 83: 588-593
- A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.J Neurosurg. 1992; 76: 772-781
- Immunotoxins and central nervous system neoplasia.J Neurosurg. 1992; 76: 1-12
- Inhibition of tumour-specific cytotoxic T-lymphocyte responses by transforming growth beta 1.Cancer Res. 1992; 52: 1386-1392
- The effects of local and systemic interferon beta (Fiblaferon) on supratentorial malignant cerebral glioma – a phase II study.Neurosurg Rev. 1991; 14: 203-213
Kondo S, Yin D, Takeuchi J, et al. Tumour necrosis factor-alpha induces an increase in susceptibility of human glioblastoma U87-MG cells to natural killer cell-mediated lysis 1994; 69: 627–632
Barba D, Saris SC, Holder C, Rosenberg SA, Oldfield EH. Intratumoral LAK cell and interleukin-2 therapy of human gliomas 1989; 70: 175–182
Central Brain Tumor Registry of the United States: Statistical Report: Primary Brain Tumors of the United States, 1992–1997. Chicago, IL: Central Brain Tumor Registry of the United States; 2000
- Randomized comparisons of radiotherapy and nitorosoureas for the treatment of malignant glioma after surgery.New Engl J Med. 1980; 303: 1323-1329
- Phase II comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.J Clin Oncol. 1993; 11: 1316-1321
- Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma.J Neurooncol. 1997; 33: 239-250
- A phase III study of radiation therapy plus carmustine with or without recombinant interferon-a in the treatment of patients with newly diagnosed high-grade glioma.Cancer. 2001; 92: 420-433
- Comparison of mixed anaplastic oligoastrocytoma and high grade astrocytoma in North Central Cancer Treatment Group (NCCTG) clinical trials of high-grade glioma (abstract).Proc Am Soc Clin Oncol. 2002; 21: 77a
- Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.J Natl Cancer Inst. 1993; 85: 704-710
Glioma Meta-Analysis Trialists (GMT) Group: Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 2002; 359: 1011–1018
- Clinical and experimental results of photodynamic therapy in neurosurgery.SPIE Proc. 1995; 2371: 126-128
- Photodynamic therapy of malignant brain tumour.Can J Neurol Sci. 1990; 17: 193-198
- Malignant glioma: who benefits from adjuvant chemotherapy?.Ann Neurol. 1998; 44: 691-695
- Phase III randomised study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbizine, N-(2-chloroethyl)-N′-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.Clin Cancer Res. 2000; 6: 3878-3884
- Phase III trial of accelerated hyperfractionation with or without difluoromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.Int J Radiat Oncol Biol Phys. 2001; 49: 71-77
- Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group Trial 9507.J Clin Oncol. 2001; 19: 1111-1117
- Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide inpatients with malignant glioma: long term results of a phase II study.J Neurooncol. 2001; 51: 133-141
- A phase II study of pre-radiation chemotherapy followed by external beam radiotherapy for the treatment of patients with newly diagnosed glioblastoma multiforme: an Eastern Cooperative Oncology Group Study (E2393).J Neurooncol. 2000; 47: 145-152
- Phase II, two-arm RTOG trial (94-11, of bischloroethyl-nitrosurea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (>20 or < or =20 cm(2), respectively) in the treatment of newly diagnosed radiosurgery-ineligible glioblastoma multiforme patients.Int J Radiat Oncol Biol Phys. 2000; 48: 1351-1358
- A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine and vincristine for glioblastoma multiforme.Int J Radiat Oncol Biol Phys. 1999; 45: 127-135
- Radiation and concomitant weekly administration of paclitaxel in patients with glioblastoma multiforme. A Phase II study.J Neurooncol. 1999; 45: 159-165
- Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study.J Neurooncol. 1999; 43: 161-166
- Selective tumour uptake of a boronated porphyrin in an animal model of cerebral glioma.Proc Natl Acad Sci. 1992; 89: 1785-1789
- Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome.J Clin Neurosci. 2004; 11: 584-596